Literature DB >> 1904498

Adenosine transport and nitrobenzylthioinosine binding in human placental membrane vesicles from brush-border and basal sides of the trophoblast.

L F Barros1, J C Bustamante, D L Yudilevich, S M Jarvis.   

Abstract

The nucleoside transport activity of human placental syncytiotrophoblast brush-border and basal membrane vesicles was compared. Adenosine and uridine were taken up into an osmotically active space. Adenosine was rapidly metabolized to inosine, metabolism was blocked by preincubating vesicles with 2'-deoxycoformycin, and subsequent adenosine uptake studies were performed in the presence of 2'-deoxycoformycin. Adenosine influx by brush-border membrane vesicles was fitted to a two-component system consisting of a saturable system with apparent Michaelis-Menten kinetics (apparent Km approx. 150 microM) and a linear component. Adenosine uptake by the saturable system was blocked by nitrobenzylthioinosine (NBMPR), dilazep, dipyridamole and other nucleosides. Inhibition by NBMPR was associated with high-affinity binding of NBMPR to the brush-border membrane vesicles (apparent Kd 0.98 +/- 0.21 nM). Binding of NBMPR to these sites was blocked by adenosine, inosine, uridine, thymidine, dilazep and dipyridamole, and the respective apparent Ki values were 0.23 +/- 0.012, 0.36 +/- 0.035, 0.78 +/- 0.1, 0.70 +/- 0.12 (mM), and 0.12 and 4.2 +/- 1.4 (nM). In contrast, adenosine influx by basal membrane vesicles was low (less than 10% of the rate observed with brush-border membrane vesicles under similar conditions), and hence no quantitative studies of adenosine uptake could be performed with these vesicles. Nevertheless, high-affinity NBMPR binding sites were demonstrated in basal membrane vesicles with similar properties to those in brush-border membrane vesicles (apparent Kd 1.05 +/- 0.13 nM and apparent Ki values for adenosine, inosine, uridine, thymidine, dilazep and dipyridamole of 0.14 +/- 0.045, 0.54 +/- 0.046, 1.26 +/- 0.20, 1.09 +/- 0.18 mM and 0.14 and 3.7 +/- 0.5 nM, respectively). Exposure of both membrane vesicles to UV light in the presence of [3H]NBMPR resulted in covalent labeling of a membrane protein(s) with a broad apparent Mr on SDS gel electropherograms of 77,000-45,000, similar to that previously reported for many other tissues, including human erythrocytes. We conclude that the maternal (brush-border) and fetal (basal) surfaces of the human placental syncytiotrophoblast possess broad-specificity, facilitated-diffusion, NBMPR-sensitive nucleoside transporters.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904498     DOI: 10.1007/bf01871414

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  41 in total

1.  Identification of a membrane adenosine deaminase binding protein from human placenta.

Authors:  P P Trotta
Journal:  Biochemistry       Date:  1982-08-17       Impact factor: 3.162

2.  Isolation and partial characterization of the basal cell membrane of human placental trophoblast.

Authors:  L K Kelley; C H Smith; B F King
Journal:  Biochim Biophys Acta       Date:  1983-09-21

3.  Nucleoside transport in Walker 256 rat carcinosarcoma and S49 mouse lymphoma cells. Differences in sensitivity to nitrobenzylthioinosine and thiol reagents.

Authors:  J A Belt; L D Noel
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

4.  Photoaffinity labeling of the human erythrocyte glucose transporter with 8-azidoadenosine.

Authors:  S M Jarvis; J D Young; J S Wu; J A Belt; A R Paterson
Journal:  J Biol Chem       Date:  1986-08-25       Impact factor: 5.157

5.  Characterization of sodium-dependent and sodium-independent nucleoside transport systems in rabbit brush-border and basolateral plasma-membrane vesicles from the renal outer cortex.

Authors:  T C Williams; A J Doherty; D A Griffith; S M Jarvis
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

6.  Nucleoside transport in human and sheep erythrocytes. Evidence that nitrobenzylthioinosine binds specifically to functional nucleoside-transport sites.

Authors:  S M Jarvis; J D Young
Journal:  Biochem J       Date:  1980-08-15       Impact factor: 3.857

7.  Membrane-associated enzymes involved in nucleoside processing by plasma membrane vesicles isolated from L929 cells grown in defined medium.

Authors:  C C Li; J Hochstadt
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

8.  Nucleoside transport in cultured mammalian cells. Multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxanthine.

Authors:  P G Plagemann; R M Wohlhueter
Journal:  Biochim Biophys Acta       Date:  1984-06-13

9.  Alanine transport systems in isolated basal plasma membrane of human placenta.

Authors:  S D Hoeltzli; C H Smith
Journal:  Am J Physiol       Date:  1989-03

10.  Glucose transport across the basal plasma membrane of human placental syncytiotrophoblast.

Authors:  L W Johnson; C H Smith
Journal:  Biochim Biophys Acta       Date:  1985-04-26
View more
  4 in total

1.  Hypoxanthine enters human vascular endothelial cells (ECV 304) via the nitrobenzylthioinosine-insensitive equilibrative nucleoside transporter.

Authors:  N Osses; J D Pearson; D L Yudilevich; S M Jarvis
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

2.  Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells.

Authors:  C E Boumah; D L Hogue; C E Cass
Journal:  Biochem J       Date:  1992-12-15       Impact factor: 3.857

3.  Immunolocalisation of nucleoside transporters in human placental trophoblast and endothelial cells: evidence for multiple transporter isoforms.

Authors:  L F Barros; D L Yudilevich; S M Jarvis; N Beaumont; J D Young; S A Baldwin
Journal:  Pflugers Arch       Date:  1995-01       Impact factor: 3.657

4.  Uridine transport in basolateral plasma membrane vesicles from rat liver.

Authors:  B Ruiz-Montasell; F Javier Casado; A Felipe; M Pastor-Anglada
Journal:  J Membr Biol       Date:  1992-06       Impact factor: 1.843

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.